These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 26113408)
1. High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma. Zhang B; Cheng B; Li FS; Ding JH; Feng YY; Zhuo GZ; Wei HF; Zhao K Tumour Biol; 2015 Dec; 36(12):9411-9. PubMed ID: 26113408 [TBL] [Abstract][Full Text] [Related]
2. The expression and clinical significance of CD73 molecule in human rectal adenocarcinoma. Zhang B; Song B; Wang X; Chang XS; Pang T; Zhang X; Yin K; Fang GE Tumour Biol; 2015 Jul; 36(7):5459-66. PubMed ID: 25677906 [TBL] [Abstract][Full Text] [Related]
3. Comment on "High expression of CD39/ENTPD1 in malignant epithelial cells of human rectal adenocarcinoma". Antonioli L; di Paolo A; Fornai M; Danesi R; Blandizzi C Tumour Biol; 2015 Sep; 36(10):7397-8. PubMed ID: 26383525 [No Abstract] [Full Text] [Related]
4. ENTPD1 (CD39) and NT5E (CD73) expression in human glioblastoma: an in silico analysis. Braganhol E; de Andrade GPB; Santos GT; Stefani MA Purinergic Signal; 2024 Jun; 20(3):285-289. PubMed ID: 37402102 [TBL] [Abstract][Full Text] [Related]
5. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139 [TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoproteins enhance expression and activity of CD39 and CD73 in the human aortic valve endothelium. Kaniewska-Bednarczuk E; Mielcarek M; Chester AH; Slominska EM; Yacoub MH; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):713-719. PubMed ID: 27906627 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression. Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736 [TBL] [Abstract][Full Text] [Related]
9. Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice. Bao R; Shui X; Hou J; Li J; Deng X; Zhu X; Yang T Int J Mol Med; 2016 Sep; 38(3):969-75. PubMed ID: 27430240 [TBL] [Abstract][Full Text] [Related]
10. Role of TGF-β signaling in generation of CD39+CD73+ myeloid cells in tumors. Ryzhov SV; Pickup MW; Chytil A; Gorska AE; Zhang Q; Owens P; Feoktistov I; Moses HL; Novitskiy SV J Immunol; 2014 Sep; 193(6):3155-64. PubMed ID: 25127858 [TBL] [Abstract][Full Text] [Related]
11. Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study. Lima CF; Tamegnon A; Rodriguez S; Maru D; Martin PL; Cooper ZA; Rodriguez-Canales J; Parra ER Pathobiology; 2024; 91(3):205-218. PubMed ID: 37926083 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5'-nucleotidase in pig endothelial cells. De Giorgi M; Pelikant-Malecka I; Sielicka A; Slominska EM; Giovannoni R; Cinti A; Cerrito MG; Lavitrano M; Smolenski RT Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):313-8. PubMed ID: 24940685 [TBL] [Abstract][Full Text] [Related]
14. Regulatory role of CD39 and CD73 in tumor immunity. Kaplinsky N; Williams K; Watkins D; Adams M; Stanbery L; Nemunaitis J Future Oncol; 2024; 20(19):1367-1380. PubMed ID: 38652041 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous accurate quantification of HO-1, CD39, and CD73 in human calcified aortic valves using multiple enzyme digestion - filter aided sample pretreatment (MED-FASP) method and targeted proteomics. Olkowicz M; Jablonska P; Rogowski J; Smolenski RT Talanta; 2018 May; 182():492-499. PubMed ID: 29501184 [TBL] [Abstract][Full Text] [Related]
16. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482 [TBL] [Abstract][Full Text] [Related]
17. CD39 and CD73 in the aortic valve-biochemical and immunohistochemical analysis in valve cell populations and its changes in valve mineralization. Kaniewska-Bednarczuk E; Kutryb-Zajac B; Sarathchandra P; Pelikant-Malecka I; Sielicka A; Piotrowska I; Slominska EM; Chester AH; Yacoub MH; Smolenski RT Cardiovasc Pathol; 2018; 36():53-63. PubMed ID: 30056298 [TBL] [Abstract][Full Text] [Related]
18. Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways. Giatromanolaki A; Kouroupi M; Pouliliou S; Mitrakas A; Hasan F; Pappa A; Koukourakis MI Life Sci; 2020 Oct; 259():118389. PubMed ID: 32898522 [TBL] [Abstract][Full Text] [Related]
19. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells. Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338 [TBL] [Abstract][Full Text] [Related]
20. Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure. Tak E; Jung DH; Kim SH; Park GC; Jun DY; Lee J; Jung BH; Kirchner VA; Hwang S; Song GW; Lee SG Toxicol Appl Pharmacol; 2017 Jan; 314():72-81. PubMed ID: 27899277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]